Literature DB >> 26415609

Isolation of Circulating Melanoma Cells.

Jie Ma1,2, Markus H Frank3,4.   

Abstract

Circulating melanoma cells (CMCs) represent critical mediators of metastatic melanoma progression. However, isolation and characterization of CMCs has been challenging due to the low frequency of these cells and the paucity of melanoma-specific cell surface markers. Herein, we describe a method for the isolation of CMCs that employs two independent markers, displays high sensitivity for CMC enrichment, and can be readily adapted to include additional molecular melanoma markers of interest. CMCs isolated by this method are enriched for ABCB5-positive melanoma stem cells, are tumorigenic in xenotransplantation assays, and can be used for phenotypical, genetic, and functional investigations of CMC biology.

Entities:  

Keywords:  ABCB5; Circulating melanoma cells; Circulating tumor cells; Flow cytometry; Melanoma stem cells; Metastasis; Tumorigenicity; Xenotransplantation

Year:  2015        PMID: 26415609      PMCID: PMC4884170          DOI: 10.1007/7651_2015_300

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro.

Authors:  M H Frank; M D Denton; S I Alexander; S J Khoury; M H Sayegh; D M Briscoe
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

2.  RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells.

Authors:  Verena Kupas; Carsten Weishaupt; Dorothee Siepmann; Maria-Laura Kaserer; Mareike Eickelmann; Dieter Metze; Thomas A Luger; Stefan Beissert; Karin Loser
Journal:  J Invest Dermatol       Date:  2011-01-27       Impact factor: 8.551

Review 3.  Molecular markers of circulating melanoma cells.

Authors:  Sandra Medic; Robert L Pearce; Peter J Heenan; Mel Ziman
Journal:  Pigment Cell Res       Date:  2007-04

4.  The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis.

Authors:  Simone Mocellin; Dave Hoon; Alessandro Ambrosi; Donato Nitti; Carlo Riccardo Rossi
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

5.  Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.

Authors:  Kazuo Koyanagi; Steven J O'Day; Peter Boasberg; Michael B Atkins; He-Jing Wang; Rene Gonzalez; Karl Lewis; John A Thompson; Clay M Anderson; Jose Lutzky; Thomas T Amatruda; Evan Hersh; Jon Richards; Jeffrey S Weber; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

6.  VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

Authors:  Natasha Y Frank; Tobias Schatton; Soo Kim; Qian Zhan; Brian J Wilson; Jie Ma; Karim R Saab; Veronika Osherov; Hans R Widlund; Martin Gasser; Ana-Maria Waaga-Gasser; Thomas S Kupper; George F Murphy; Markus H Frank
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

7.  ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.

Authors:  Natasha Y Frank; Armen Margaryan; Ying Huang; Tobias Schatton; Ana Maria Waaga-Gasser; Martin Gasser; Mohamed H Sayegh; Wolfgang Sadee; Markus H Frank
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

8.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

9.  Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.

Authors:  Alexander D Boiko; Olga V Razorenova; Matt van de Rijn; Susan M Swetter; Denise L Johnson; Daphne P Ly; Paris D Butler; George P Yang; Benzion Joshua; Michael J Kaplan; Michael T Longaker; Irving L Weissman
Journal:  Nature       Date:  2010-07-01       Impact factor: 49.962

10.  In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser.

Authors:  Ekaterina I Galanzha; Evgeny V Shashkov; Paul M Spring; James Y Suen; Vladimir P Zharov
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

View more
  2 in total

Review 1.  Lymph node dissection for melanoma: where do we stand?

Authors:  Madalyn G Neuwirth; Edmund K Bartlett; Giorgos C Karakousis
Journal:  Melanoma Manag       Date:  2017-03-03

2.  Salmonella VNP20009-mediated RNA interference of ABCB5 moderated chemoresistance of melanoma stem cell and suppressed tumor growth more potently.

Authors:  Xiaoxin Zhang; Xiawei Cheng; Yueyang Lai; Yuqiang Zhou; Wenmin Cao; Zi-Chun Hua
Journal:  Oncotarget       Date:  2016-03-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.